🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Craniosynostoses

Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts NCT04159675n/a1 site📍 Bron Hospices Civils de Lyon · Tests: osteoblast biology study A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 NCT07292168Phase 1, Phase 25 sites📍 Kazan'📍 Krasnoyarsk📍 Moscow Kidney Cancer Research Bureau · Tests: humanized monoclonal anti-FGFR1 antibody OM-RCA-01 Ocular Characteristics in Patients With Craniosynostosis NCT06928727n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens GROWing Up With Rare GENEtic Syndromes NCT04463316n/a1 site📍 Rotterdam dr. Laura C. G. de Graaff-Herder · Tests: Retrospective file studies Comparing Conservative to Surgical Treatment of Trigonocephaly Craniofacial Surgery in Children With Trigonocephaly: an Observational Cohort Study on Clinical Outcomes, Psychosocial Wellbeing, and Costs NCT06069479n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: craniofacial surgery Hemodynamic Monitoring During Craniosynostosis Surgery: Comparing Traditional and Newer Technology Monitors (CRASY-PRAM) NCT06263075n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Intraoperative monitoring Pleth Variability Index Monitoring in Pediatric Craniosynostosis Surgery NCT07657598n/a1 site📍 Istanbul Muzaffer GENCER ASO Treatment for Syndromic Craniosynostoses NCT07535372n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Design of patient specific ASO Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer NCT07710885Phase 321 sites📍 Brisbane📍 Melbourne📍 Perth Taiho Pharmaceutical Co., Ltd. · Tests: Futibatinib, Zimberelimab, Durvalumab, Pembrolizumab, Gemcitabine Effectiveness of Repositioning and Cranial Remolding in Infants With Cranial Deformation NCT05917678NA1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Repositioning Therapy, Cranial Remolding Orthosis NCCH2006/MK010 Trial (FORTUNE Trial) NCT04962867Phase 27 sites📍 Chuo-ku, Tokyo📍 Yokohama📍 Aoba-ku, Sendai, Miyagi National Cancer Center, Japan · Tests: E7090
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy